These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 2249877)

  • 1. Interleukin-1 and tumour necrosis factor alpha induced polymorphonuclear leukocyte-endothelial cell adhesion and transendothelial migration in vitro: the effect of apical versus basal monolayer stimulation.
    Morzycki W; Sadowska J; Issekutz AC
    Immunol Lett; 1990 Sep; 25(4):331-40. PubMed ID: 2249877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration.
    Drake WT; Lopes NN; Fenton JW; Issekutz AC
    Lab Invest; 1992 Nov; 67(5):617-27. PubMed ID: 1434539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin activation of endothelium for polymorphonuclear leucocyte transendothelial migration and modulation by interferon-gamma.
    Issekutz AC; Lopes N
    Immunology; 1993 Aug; 79(4):600-7. PubMed ID: 8104889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy between tumour necrosis factor alpha and interleukin-1 in the induction of polymorphonuclear leukocyte migration during inflammation.
    Wankowicz Z; Megyeri P; Issekutz A
    J Leukoc Biol; 1988 Apr; 43(4):349-56. PubMed ID: 3258346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor-alpha but not interleukin-1 induces polymorphonuclear leucocyte migration through fibroblast layers by a fibroblast-dependent mechanism.
    Morzycki W; Issekutz AC
    Immunology; 1991 Sep; 74(1):107-13. PubMed ID: 1937564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanisms.
    Issekutz AC; Chuluyan HE; Lopes N
    J Leukoc Biol; 1995 Apr; 57(4):553-61. PubMed ID: 7722414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1 activation of endothelium supports VLA-4 (CD49d/CD29)-mediated monocyte transendothelial migration to C5a, MIP-1 alpha, RANTES, and PAF but inhibits migration to MCP-1: a regulatory role for endothelium-derived MCP-1.
    Chuluyan HE; Schall TJ; Yoshimura T; Issekutz AC
    J Leukoc Biol; 1995 Jul; 58(1):71-9. PubMed ID: 7542307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Ebselen on polymorphonuclear leukocyte adhesion to and migration through cytokine-activated vascular endothelium.
    Issekutz AC; Lopes N
    Int J Immunopharmacol; 1992 Nov; 14(8):1383-90. PubMed ID: 1464470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage.
    Moser R; Schleiffenbaum B; Groscurth P; Fehr J
    J Clin Invest; 1989 Feb; 83(2):444-55. PubMed ID: 2643630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha-induced transendothelial neutrophil migration is IL-8 dependent.
    Smart SJ; Casale TB
    Am J Physiol; 1994 Mar; 266(3 Pt 1):L238-45. PubMed ID: 8166294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factor regulation of neutrophil-endothelial cell interactions.
    Zhang H; Issekutz AC
    J Leukoc Biol; 2001 Aug; 70(2):225-32. PubMed ID: 11493614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-induced sequential migration of neutrophils through endothelium and epithelium.
    Casale TB; Carolan EJ
    Inflamm Res; 1999 Jan; 48(1):22-7. PubMed ID: 9987679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine activation of human macro- and microvessel-derived endothelial cells.
    Gerritsen ME; Niedbala MJ; Szczepanski A; Carley WW
    Blood Cells; 1993; 19(2):325-39; discussion 340-2. PubMed ID: 7906155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with interleukin-1 or tumor necrosis factor-alpha.
    Furie MB; McHugh DD
    J Immunol; 1989 Nov; 143(10):3309-17. PubMed ID: 2553810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of venous shear stress on CD18-mediated neutrophil adhesion to cultured endothelium.
    Lawrence MB; Smith CW; Eskin SG; McIntire LV
    Blood; 1990 Jan; 75(1):227-37. PubMed ID: 1967215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of protein tyrosine kinase inhibitors on cytokine-induced adhesion molecule expression by human umbilical vein endothelial cells.
    May MJ; Wheeler-Jones CP; Pearson JD
    Br J Pharmacol; 1996 Aug; 118(7):1761-71. PubMed ID: 8842442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha is necessary for granulocyte-macrophage-colony-stimulating-factor-induced eosinophil transendothelial migration.
    Erger RA; Casale TB
    Int Arch Allergy Immunol; 1998 Jan; 115(1):24-32. PubMed ID: 9430492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1.
    Cid MC; Kleinman HK; Grant DS; Schnaper HW; Fauci AS; Hoffman GS
    J Clin Invest; 1994 Jan; 93(1):17-25. PubMed ID: 7506711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration.
    Ebisawa M; Bochner BS; Georas SN; Schleimer RP
    J Immunol; 1992 Dec; 149(12):4021-8. PubMed ID: 1460288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differing mechanisms of leukocyte recruitment and sensitivity to conditioning by shear stress for endothelial cells treated with tumour necrosis factor-alpha or interleukin-1beta.
    Sheikh S; Rahman M; Gale Z; Luu NT; Stone PC; Matharu NM; Rainger GE; Nash GB
    Br J Pharmacol; 2005 Aug; 145(8):1052-61. PubMed ID: 15912126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.